BTIG Research Cuts Billiontoone (NASDAQ:BLLN) Price Target to $140.00

Billiontoone (NASDAQ:BLLN) had its price objective decreased by BTIG Research from $160.00 to $140.00 in a report issued on Thursday morning, MarketBeat.com reports. BTIG Research currently has a buy rating on the stock.

A number of other research firms have also recently weighed in on BLLN. Zacks Research raised shares of Billiontoone to a “hold” rating in a report on Tuesday, December 2nd. William Blair assumed coverage on shares of Billiontoone in a report on Monday, December 1st. They issued an “outperform” rating for the company. JPMorgan Chase & Co. dropped their target price on shares of Billiontoone from $150.00 to $145.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 10th. Wall Street Zen upgraded shares of Billiontoone to a “hold” rating in a research note on Saturday, November 15th. Finally, Piper Sandler restated an “overweight” rating on shares of Billiontoone in a research note on Wednesday, December 10th. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $129.57.

Billiontoone Stock Up 1.9%

Shares of NASDAQ:BLLN opened at $73.51 on Thursday. The stock has a market capitalization of $3.36 billion and a PE ratio of 735.10. The company’s fifty day moving average is $85.55. Billiontoone has a 12-month low of $66.00 and a 12-month high of $138.70.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, March 4th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.04 by $0.07. The business had revenue of $96.05 million during the quarter, compared to analysts’ expectations of $85.85 million. Billiontoone’s revenue was up 113.0% compared to the same quarter last year.

Institutional Trading of Billiontoone

Hedge funds and other institutional investors have recently modified their holdings of the business. Rossby Financial LCC acquired a new position in shares of Billiontoone in the fourth quarter worth about $25,000. Wells Fargo & Company MN acquired a new position in shares of Billiontoone in the 4th quarter valued at approximately $76,000. Smartleaf Asset Management LLC purchased a new position in shares of Billiontoone during the 4th quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone during the 4th quarter valued at approximately $82,000. Finally, Renaissance Capital LLC acquired a new stake in shares of Billiontoone during the fourth quarter worth approximately $201,000.

Trending Headlines about Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q4 earnings beat and rapid revenue growth — BillionToOne reported $0.11 EPS vs. $0.04 consensus and revenue of $96.05M (vs. $85.85M est.), with revenue up ~113% year-over-year; results and commentary point to accelerating demand. View Press Release
• Positive Sentiment: Raised FY‑2026 revenue guidance — company lifted 2026 revenue guidance to $430M–$445M vs. consensus near $356M, implying materially stronger top‑line growth than analysts expected. Press Release
• Positive Sentiment: Earnings call & investor materials highlight strategy and growth drivers — management commentary and the slide deck underscored durable revenue expansion and product/market traction that support the raised guidance. Earnings Highlights
• Positive Sentiment: Analyst support: Guggenheim reaffirmed a “buy” with a $120 PT — another buy-side vote that can buoy sentiment despite mixed firm-level price target moves. Benzinga
• Positive Sentiment: Positive coverage piece framing BLLN as an attractive investment — broader bullish narratives and coverage can amplify buying interest following the beat and guidance lift. Article
• Neutral Sentiment: Analyst deep‑dive and metric comparisons — outlets (e.g., Zacks) are parsing metrics vs. estimates and prior periods; useful for modeling but not new catalyst. Zacks
• Neutral Sentiment: Q4 snapshot pieces summarize results for retail/institutional readers — helpful context but unlikely to move price independently. LMOnline
• Neutral Sentiment: Short‑interest data appears anomalous/unchanged (reports show zeros/NaN); no clear short squeeze signal from these feeds. (Data quality issue; monitor official FINRA reports.)
• Negative Sentiment: Wells Fargo cut its price target to $90 and set an “equal weight” rating — a downgrade in conviction from that shop could cap near‑term upside and weigh on sentiment for more conservative investors. Benzinga
• Negative Sentiment: BTIG trimmed its target from $160 to $140 (still a “buy”) — target cuts reduce the extent of analyst-driven upside, even if the rating remains positive. Street Insider

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.